Laurence Lacotte‐Thierry

Thalidomide versus placebo in myeloid metaplasia with myelofibrosis: a prospective, randomized, double-blind, multicenter study.

Jean‐François Abgrall, Isabelle Guibaud, Jean Bastié et al. · PubMed · 2006 · 47 citations

Medicine, Hematology, Pharmacology +15

Chemotherapy with rituximab followed by high‐dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma

Catherine Thiéblemont, Daciana Antal, Laurence Lacotte‐Thierry et al. · Cancer · 2005 · 35 citations · Full text

Medicine, Hematology, Oncology +15

A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma: The GOELAMS LCP 99 trial

Gaëlle Olivier, Aline Clavert, Laurence Lacotte‐Thierry et al. · American Journal of Hematology · 2014 · 27 citations · Full text

Medicine, Oncology, Pharmacology +11

Interferon-alpha: mechanisms of action in chronic myelogenous leukemia in chronic phase.

François Guilhot, Laurence Lacotte‐Thierry · PubMed · 1998 · 27 citations

Medicine, Hematology, Oncology +10